1. Introduction

   • Lionel H. Opie
   • Franz H. Messerli

   EditorialNotes Pages: 531 - 531

2. Review policy for supplements

   Acknowledgments Pages: 532 - 532

3. Myocardial stunning—Are calcium antagonists useful?

   • Lionel H. Opie

   OriginalPaper Pages: 533 - 541

4. Review of postinfarct treatment with verapamil: Combined experience of early and late intervention studies with verapamil in patients with acute myocardial infarction

   • Jørgen Fischer Hansen

   ReviewPaper Pages: 543 - 547

5. Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality

   • Elieser Kaplinsky

   OriginalPaper Pages: 549 - 556

6. Ventricular dysrhythmias, left ventricular hypertrophy, and sudden death

   • Franz H. Messerli
   • Federico Soria

   OriginalPaper Pages: 557 - 563

7. How do calcium antagonists differ in clinical practice?

   • R. Ferrari
   • F. Cucchini
   • O. Visioli

   OriginalPaper Pages: 565 - 575